Literature DB >> 7295629

Amino acids in retinitis pigmentosa.

S A Arshinoff, J C McCulloch, W Macrae, A N Stein, E B Marliss.   

Abstract

A survey of fasting whole blood amino acids in 65 patients with various subtypes of retinitis pigmentosa performed. Eight X-linked recessive patients showed decreased taurine and aspartate. Nineteen autosomal recessive patients, and to lesser extent 10 autosomal dominant patients, showed reduced levels of whole blood threonine and histidine. Branched-chain amino acids and arginine were present in increased amounts in 2 patients with Laurence-Moon-Bardet-Biedl syndrome. These findings in LMBB patients are probably related in part to their obesity and emphasise that appropriate controls are required, and other factors (including age) known to affect amino acid levels must be accounted for. The biochemical implications of our findings are not yet apparent.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295629      PMCID: PMC1039610          DOI: 10.1136/bjo.65.9.626

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Retinal degeneration in cats fed casein. I. Taurine deficiency.

Authors:  S Y Schmidt; E L Berson; K C Hayes
Journal:  Invest Ophthalmol       Date:  1976-01

2.  BIOCHEMICAL FINDINGS IN HUMAN RETINITIS PIGMENTOSA WITH PARTICULAR RELATION TO VITAMIN A DEFICIENCY.

Authors:  D A Campbell; E L Tonks
Journal:  Br J Ophthalmol       Date:  1962-03       Impact factor: 4.638

3.  [Biochemical studies on retinitis pigmentosa. 3. Study on amino acid metabolism of patients with retinitis pigmentosa].

Authors:  H Fujiwara
Journal:  Nihon Ganka Kiyo       Date:  1968-07

4.  Plasma amino acid levels and insulin secretion in obesity.

Authors:  P Felig; E Marliss; G F Cahill
Journal:  N Engl J Med       Date:  1969-10-09       Impact factor: 91.245

5.  Hyperornithinaemia and gyrate atrophy of the retina: improvement of vision during treatment with a low-arginine diet.

Authors:  R R McInnes; S A Arshinoff; L Bell; E B Marliss; J C McCulloch
Journal:  Lancet       Date:  1981-03-07       Impact factor: 79.321

6.  Uptake of taurine by platelets in retinitis pigmentosa.

Authors:  E M Airaksinen; P Sihvola; M M Airaksinen; M Sihvola; E Tuovinen
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

7.  Amino-acid metabolism and liver ultrastructure in hyperornithinemia with gyrate atrophy of the choroid and retina.

Authors:  S A Arshinoff; J C McCulloch; Y Matuk; M J Phillips; B A Gordon; E B Marliss
Journal:  Metabolism       Date:  1979-10       Impact factor: 8.694

8.  Plasma amino-acids in hereditary retinal disease. Ornithine, lysine, and taurine.

Authors:  E L Berson; S Y Schmidt; A R Rabin
Journal:  Br J Ophthalmol       Date:  1976-02       Impact factor: 4.638

9.  Hyperornithinemia and gyrate atrophy of the choroid and retina.

Authors:  J C McCulloch; S A Arshinoff; E B Marliss; J A Parker
Journal:  Ophthalmology       Date:  1978-09       Impact factor: 12.079

10.  The metabolic response to hypocaloric protein diets in obese man.

Authors:  E B Marliss; F T Murray; A F Nakhooda
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

  10 in total
  1 in total

1.  Systemic taurine treatment provides neuroprotection against retinal photoreceptor degeneration and visual function impairments.

Authors:  Ye Tao; Miao He; Qinghua Yang; Zhao Ma; Yingxin Qu; Wen Chen; Guanghua Peng; Dengke Teng
Journal:  Drug Des Devel Ther       Date:  2019-08-07       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.